These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 3513777

  • 21. General pharmacological profile of the novel muscarinic receptor agonist SNI-2011, a drug for xerostomia in Sjögren's syndrome. 2nd communication: effects on somatic nervous system and on autonomic nervous system and smooth muscle.
    Arisawa H, Fukui K, Fujise N, Masunaga H.
    Arzneimittelforschung; 2002; 52(2):81-8. PubMed ID: 11878203
    [Abstract] [Full Text] [Related]

  • 22. General pharmacological properties of the new angiotensin II receptor antagonist (+/-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl) biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate. Part I: Effects on central nervous system and other properties.
    Kito G, Morimoto S, Shiomi M.
    Arzneimittelforschung; 1996 Jun; 46(6):572-9. PubMed ID: 8767346
    [Abstract] [Full Text] [Related]

  • 23. General pharmacology of beraprost sodium. 2nd communication: effect on the autonomic, cardiovascular and gastrointestinal systems, and other effects.
    Murata T, Murai T, Kanai T, Ogaki Y, Sanai K, Kanda H, Sato S, Kajikawa N, Umetsu T, Matsuura H.
    Arzneimittelforschung; 1989 Aug; 39(8):867-76. PubMed ID: 2510743
    [Abstract] [Full Text] [Related]

  • 24. Possible involvement of ATP-dependent K-channel related mechanisms in the antihypertensive and cough suppressant effects of the novel ACE inhibitor (2S, 3aS, 7aS)-1-(N2-nicotinoyl-L-lysyl-gamma-D-glutamyl)octahydro-1H- indole-2-carboxylic acid.
    Nagata S, Takeyama K, Hosoki K, Karasawa T.
    Arzneimittelforschung; 1997 Jun; 47(6):726-30. PubMed ID: 9239450
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Metabolism of protein conjugate of desacetyl-alacepril and its effect on angiotensin converting enzyme in renal hypertensive rats.
    Matsumoto K, Nambu K, Fujii T, Takeyama K, Miyazaki H, Hashimoto M.
    Arzneimittelforschung; 1986 Jun; 36(1):52-4. PubMed ID: 3006711
    [Abstract] [Full Text] [Related]

  • 28. General pharmacological properties of muroctasin.
    Kojima H, Hirohashi M, Kasai Y, Takasuna K, Fukumoto C, Akashi A.
    Arzneimittelforschung; 1988 Jul; 38(7A):1002-9. PubMed ID: 3190791
    [Abstract] [Full Text] [Related]

  • 29. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
    Osada E, Murai T, Ishizaka Y, Sanai K.
    Arzneimittelforschung; 1984 Jul; 34(11A):1641-51. PubMed ID: 6152157
    [Abstract] [Full Text] [Related]

  • 30. General pharmacology of the new non-xanthine adenosine A1 receptor antagonist (+)-(R)-[(E)-3-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)acryloyl]-2- piperidine ethanol.
    Terai T, Kusunoki T, Kita Y, Yoshida K, Akahane A, Shiokawa Y, Kohno Y, Horiai H, Mori J, Mine Y, Kohsaka M.
    Arzneimittelforschung; 1996 Feb; 46(2):185-91. PubMed ID: 8720311
    [Abstract] [Full Text] [Related]

  • 31. General pharmacological profile of the new anti-ulcer drug 3-[[[2-(3,4-dimethoxyphenyl)ethyl]carbamoyl]methyl]-amino-N -methylbenzamide.
    Hirohashi M, Takasuna K, Kasai Y, Usui C, Tamura K, Kojima H.
    Arzneimittelforschung; 1993 May; 43(5):569-77. PubMed ID: 8329002
    [Abstract] [Full Text] [Related]

  • 32. Effect of alacepril on renin-angiotensin-aldosterone system and kallikrein-kinin-prostaglandin system in experimental animals.
    Hosoki K, Takeyama K, Minato H, Fukuya F, Kawahara S, Kadokawa T.
    Arzneimittelforschung; 1986 May; 36(1):77-83. PubMed ID: 3006712
    [Abstract] [Full Text] [Related]

  • 33. Disposition and metabolism of the novel antihypertensive agent alacepril in rats.
    Matsumoto K, Miyazaki H, Fujii T, Yoshida K, Amejima H, Hashimoto M.
    Arzneimittelforschung; 1986 May; 36(1):40-6. PubMed ID: 3513776
    [Abstract] [Full Text] [Related]

  • 34. [Pharmacological studies of guanabenz. Effects on the peripheral nervous and other organ systems].
    Ohata K, Murata T, Sakamoto H, Kohno S, Hojo M, Yoshida Y, Nagasaka Y, Akimoto Y, Shimada A, Teramoto N, Tatsumi H.
    Nihon Yakurigaku Zasshi; 1983 Jan; 81(1):59-78. PubMed ID: 6852682
    [Abstract] [Full Text] [Related]

  • 35. General pharmacological profiles of the new beta-adrenoceptor antagonist carvedilol.
    Hirohashi M, Takasuna K, Tamura K, Yamaguchi K, Maekawa K, Yamada S, Iwasaki S, Yoshida M, Nomura M, Taguchi K.
    Arzneimittelforschung; 1990 Jul; 40(7):735-46. PubMed ID: 1977393
    [Abstract] [Full Text] [Related]

  • 36. Sulfonyliminoimidazolidines, a new class of oral hypoglycemic agents. 4. Toxicity and general pharmacology of 1-[p-[2-(crotonylamino)-ethyl]-phenylsulfonyl]-3-cyclohexy l-2-imino- imidazolidine (CGP 11 112).
    Märki F, Büch O, Delini-Stula A, Kraetz J, Petermann H, Radeke E, Schweizer A, Thomann P, Truog A.
    Arzneimittelforschung; 1984 Jul; 34(3):247-52. PubMed ID: 6539603
    [Abstract] [Full Text] [Related]

  • 37. [General pharmacology of T-3761, a new oral quinolone antibacterial agent (2). Effect on the respiratory and cardiovascular systems, autonomic nervous system and other functions].
    Furuhata K, Hiraiwa T, Terashima N, Arai H, Ono S, Hashiba K, Maekawa M, Kitamura K, Nakada Y, Mori Y.
    Jpn J Antibiot; 1995 May; 48(5):706-32. PubMed ID: 7637205
    [Abstract] [Full Text] [Related]

  • 38. Pharmacological studies on timiperone, a new neuroleptic drug Part II: General pharmacological properties.
    Yamasaki T, Kojima H, Tanaka M, Aibara S, Hirohashi M, Kasai Y, Tsubokawa M, Watanabe K, Akashi A.
    Arzneimittelforschung; 1981 May; 31(4):707-15. PubMed ID: 6113834
    [Abstract] [Full Text] [Related]

  • 39. General pharmacology of the new quinolone antibacterial agent levofloxacin.
    Takasuna K, Kasai Y, Usui C, Takahashi M, Hirohashi M, Tamura K, Takayama S.
    Arzneimittelforschung; 1992 Mar; 43(3A):408-18. PubMed ID: 1622443
    [Abstract] [Full Text] [Related]

  • 40. [General pharmacology of T-3262, a new pyridonecarboxylic acid].
    Hirai S, Hiraiwa T, Arai H, Ono S, Tanaka K, Hashiba K, Nakada Y, Goden K, Tanada K, Maekawa M.
    Jpn J Antibiot; 1989 Apr; 42(4):831-53. PubMed ID: 2769937
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.